Suppr超能文献

慢性全身糖皮质激素治疗的副作用:皮肤科医生应该知道什么。

Side effects of chronic systemic glucocorticoid therapy: what dermatologists should know.

机构信息

Department of Tropical Medicine and Dermatology, Hospital das Clínicas da Universidade Federal de Goiás, Goiânia, Goiás, Brazil.

Department of Tropical Medicine and Dermatology, Hospital das Clínicas da Universidade Federal de Goiás, Goiânia, Goiás, Brazil.

出版信息

An Bras Dermatol. 2024 Mar-Apr;99(2):259-268. doi: 10.1016/j.abd.2023.05.005. Epub 2023 Nov 24.

Abstract

In dermatologists' clinical practice, the use of systemic glucocorticoids is recurrent for the management of different comorbidities that require chronic immunosuppression. The prescription of this medication requires caution and basic clinical knowledge due to the several adverse effects inherent to the treatment. However, different doubts may arise or inappropriate conduct may be adopted due to the lack of objective and specific guidelines for the screening, prophylaxis and management of complications from chronic corticosteroid therapy. Considering this problem, the authors carried out a narrative review of the literature to gather up-to-date data on adverse effects secondary to the chronic use of systemic glucocorticoids. The broad approach to this topic made it possible to review the pathophysiology and risk factors for these complications, as well as to develop updated orientation that can be used as a learning tool and quick reference for dermatologists during their clinical practice with glucocorticoids.

摘要

在皮肤科医生的临床实践中,为了治疗需要慢性免疫抑制的不同合并症,经常会用到全身性糖皮质激素。由于治疗本身固有的多种不良反应,开具此类药物需要谨慎并具备基本的临床知识。然而,由于缺乏针对慢性皮质类固醇治疗并发症的筛查、预防和管理的客观和具体指南,可能会出现不同的疑问或不适当的行为。鉴于这个问题,作者对文献进行了叙述性综述,以收集有关慢性使用全身性糖皮质激素引起的不良反应的最新数据。对这个主题的广泛探讨使我们能够回顾这些并发症的病理生理学和危险因素,并制定最新的指导方针,以便在皮肤科医生使用糖皮质激素进行临床实践时,作为学习工具和快速参考。

相似文献

1
Side effects of chronic systemic glucocorticoid therapy: what dermatologists should know.
An Bras Dermatol. 2024 Mar-Apr;99(2):259-268. doi: 10.1016/j.abd.2023.05.005. Epub 2023 Nov 24.
2
Systemic glucocorticoids: important issues and practical guidelines for the dermatologist.
Int J Dermatol. 2015 Jun;54(6):723-9. doi: 10.1111/ijd.12642. Epub 2015 Feb 13.
4
Long-term side effects of glucocorticoids.
Expert Opin Drug Saf. 2016;15(4):457-65. doi: 10.1517/14740338.2016.1140743. Epub 2016 Feb 6.
5
Prevention and treatment of systemic glucocorticoid side effects.
Int J Dermatol. 2010 Mar;49(3):239-48. doi: 10.1111/j.1365-4632.2009.04322.x.
6
Dermatologists' Knowledge and Attitude Toward Isotretinoin Ocular Side Effects in Egypt.
Clin Cosmet Investig Dermatol. 2021 Sep 18;14:1295-1301. doi: 10.2147/CCID.S327870. eCollection 2021.
7
Systemic comorbidities of rosacea: practice gaps among dermatologists.
Arch Dermatol Res. 2022 Dec;314(10):995-997. doi: 10.1007/s00403-021-02279-y. Epub 2021 Sep 12.
9
Short-term glucocorticoid-related side effects and adverse reactions: a narrative review and practical approach.
Swiss Med Wkly. 2022 Jan 7;152:w30088. doi: 10.4414/smw.2022.w30088. eCollection 2022 Jan 3.

引用本文的文献

本文引用的文献

2
Glucocorticoid induced adrenal insufficiency.
BMJ. 2021 Jul 12;374:n1380. doi: 10.1136/bmj.n1380.
3
Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance.
Int J Mol Sci. 2021 Jan 9;22(2):623. doi: 10.3390/ijms22020623.
4
Glucocorticoid-induced cardiomyopathy: unexpected conclusion.
BMJ Case Rep. 2020 Nov 9;13(11):e237173. doi: 10.1136/bcr-2020-237173.
5
How should rheumatologists manage glucocorticoid-induced hyperglycemia?
Mod Rheumatol. 2021 May;31(3):519-528. doi: 10.1080/14397595.2020.1823060. Epub 2020 Oct 7.
6
Long-term systemic glucocorticoid therapy and weight gain: a population-based cohort study.
Rheumatology (Oxford). 2021 Mar 2;60(3):1502-1511. doi: 10.1093/rheumatology/keaa289.
7
Glucocorticoid use is associated with an increased risk of hypertension.
Rheumatology (Oxford). 2021 Jan 5;60(1):132-139. doi: 10.1093/rheumatology/keaa209.
8
Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis.
Expert Rev Endocrinol Metab. 2020 Jul;15(4):283-298. doi: 10.1080/17446651.2020.1772051. Epub 2020 Jun 25.
9
Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment.
Nat Rev Endocrinol. 2020 Aug;16(8):437-447. doi: 10.1038/s41574-020-0341-0. Epub 2020 Apr 14.
10
Steroid-induced glaucoma: Epidemiology, pathophysiology, and clinical management.
Surv Ophthalmol. 2020 Jul-Aug;65(4):458-472. doi: 10.1016/j.survophthal.2020.01.002. Epub 2020 Feb 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验